Your browser doesn't support javascript.
loading
Development of a Human Antibody Cocktail that Deploys Multiple Functions to Confer Pan-Ebolavirus Protection.
Wec, Anna Z; Bornholdt, Zachary A; He, Shihua; Herbert, Andrew S; Goodwin, Eileen; Wirchnianski, Ariel S; Gunn, Bronwyn M; Zhang, Zirui; Zhu, Wenjun; Liu, Guodong; Abelson, Dafna M; Moyer, Crystal L; Jangra, Rohit K; James, Rebekah M; Bakken, Russell R; Bohorova, Natasha; Bohorov, Ognian; Kim, Do H; Pauly, Michael H; Velasco, Jesus; Bortz, Robert H; Whaley, Kevin J; Goldstein, Tracey; Anthony, Simon J; Alter, Galit; Walker, Laura M; Dye, John M; Zeitlin, Larry; Qiu, Xiangguo; Chandran, Kartik.
Afiliação
  • Wec AZ; Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
  • Bornholdt ZA; Mapp Biopharmaceutical, San Diego, CA 92121, USA.
  • He S; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB R3E 3R2, Canada.
  • Herbert AS; U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, MD 21702, USA.
  • Goodwin E; Adimab, LLC, Lebanon, NH 03766, USA.
  • Wirchnianski AS; Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
  • Gunn BM; Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, USA.
  • Zhang Z; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB R3E 3R2, Canada; Department of Medical Microbiology, University of Manitoba, Winnipeg, MB R3E 0J9, Canada.
  • Zhu W; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB R3E 3R2, Canada; Department of Medical Microbiology, University of Manitoba, Winnipeg, MB R3E 0J9, Canada.
  • Liu G; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB R3E 3R2, Canada; Department of Medical Microbiology, University of Manitoba, Winnipeg, MB R3E 0J9, Canada.
  • Abelson DM; Mapp Biopharmaceutical, San Diego, CA 92121, USA.
  • Moyer CL; Mapp Biopharmaceutical, San Diego, CA 92121, USA.
  • Jangra RK; Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
  • James RM; U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, MD 21702, USA.
  • Bakken RR; U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, MD 21702, USA.
  • Bohorova N; Mapp Biopharmaceutical, San Diego, CA 92121, USA.
  • Bohorov O; Mapp Biopharmaceutical, San Diego, CA 92121, USA.
  • Kim DH; Mapp Biopharmaceutical, San Diego, CA 92121, USA.
  • Pauly MH; Mapp Biopharmaceutical, San Diego, CA 92121, USA.
  • Velasco J; Mapp Biopharmaceutical, San Diego, CA 92121, USA.
  • Bortz RH; Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
  • Whaley KJ; Mapp Biopharmaceutical, San Diego, CA 92121, USA.
  • Goldstein T; One Health Institute and Karen C. Drayer Wildlife Health Center, School of Veterinary Medicine, University of California, Davis, Davis, CA 95616, USA.
  • Anthony SJ; Center for Infection and Immunity, Mailman School of Public Health, Columbia University, New York, NY 10032, USA.
  • Alter G; Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, USA.
  • Walker LM; Adimab, LLC, Lebanon, NH 03766, USA.
  • Dye JM; U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, MD 21702, USA.
  • Zeitlin L; Mapp Biopharmaceutical, San Diego, CA 92121, USA. Electronic address: larry.zeitlin@mappbio.com.
  • Qiu X; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB R3E 3R2, Canada; Department of Medical Microbiology, University of Manitoba, Winnipeg, MB R3E 0J9, Canada. Electronic address: xiangguo.qiu@canada.ca.
  • Chandran K; Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY 10461, USA. Electronic address: kartik.chandran@einstein.yu.edu.
Cell Host Microbe ; 25(1): 39-48.e5, 2019 01 09.
Article em En | MEDLINE | ID: mdl-30629917

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença pelo Vírus Ebola / Ebolavirus / Anticorpos Monoclonais / Anticorpos Antivirais Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença pelo Vírus Ebola / Ebolavirus / Anticorpos Monoclonais / Anticorpos Antivirais Idioma: En Ano de publicação: 2019 Tipo de documento: Article